Free Trial

Labcorp (LH) Stock Forecast & Price Target

Labcorp logo
$250.30 -3.72 (-1.47%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$250.58 +0.28 (+0.11%)
As of 05/15/2026 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Labcorp - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
3
Buy
8

Based on 11 Wall Street analysts who have issued ratings for Labcorp in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 11 analysts, 3 have given a hold rating, and 8 have given a buy rating for LH.

Consensus Price Target

$308.00
23.05% Upside
According to the 11 analysts' twelve-month price targets for Labcorp, the average price target is $308.00. The highest price target for LH is $334.00, while the lowest price target for LH is $260.00. The average price target represents a forecasted upside of 23.05% from the current price of $250.30.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for LH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Labcorp and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LH Analyst Ratings Over Time

TypeCurrent Forecast
5/17/25 to 5/17/26
1 Month Ago
4/17/25 to 4/17/26
3 Months Ago
2/16/25 to 2/16/26
1 Year Ago
5/17/24 to 5/17/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
8 Buy rating(s)
8 Buy rating(s)
10 Buy rating(s)
10 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$308.00$307.20$300.75$270.62
Forecasted Upside23.05% Upside13.44% Upside6.41% Upside8.42% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

LH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Labcorp Stock vs. The Competition

TypeLabcorpMedical CompaniesBroader Market
Consensus Rating Score
2.73
2.30
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside23.05% Upside1,822.52% Upside17.90% Upside
News Sentiment Rating
Positive News

See Recent LH News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
5/8/2026 Reiterated RatingBuy (B-)
5/1/2026
Robert W. Baird logo
Robert W. Baird
3 of 5 stars
Eric Coldwell
Eric Coldwell
2 of 5 stars
Set Target$334.00+30.77%
4/8/2026
Evercore Inc logo
Evercore
4 of 5 stars
 Reiterated RatingOutperform$300.00+14.07%
2/24/2026Boost TargetNeutral$270.00 ➝ $300.00+5.21%
2/18/2026Boost TargetOverweight$319.00 ➝ $330.00+17.64%
2/17/2026 Reiterated RatingOverweight
10/29/2025Lower TargetBuy$325.00 ➝ $320.00+25.57%
10/17/2025Boost TargetOutperform$285.00 ➝ $320.00+12.84%
10/14/2025Set Target$320.00+14.51%
10/2/2025Boost TargetEqual Weight$275.00 ➝ $290.00+3.81%
7/10/2025DowngradeBuyHold$260.00+2.70%
4/2/2025Initiated CoverageBuy$276.00+18.64%
3/4/2025UpgradeNeutralBuy$250.00 ➝ $300.00+18.11%
2/6/2025Boost TargetBuy$275.00 ➝ $290.00+17.25%
12/13/2024 Boost TargetBuy$262.00 ➝ $271.00+16.67%
8/2/2024 Boost TargetHold$220.00 ➝ $230.00-2.35%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 01:54 PM ET.


Should I Buy Labcorp Stock? LH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, May 16, 2026. Please send any questions or comments about these Labcorp pros and cons to contact@marketbeat.com.

Labcorp
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Laboratory Co. of America Holdings:

  • The company has set its fiscal year 2026 guidance for earnings per share (EPS) between 17.700 and 18.350, indicating a strong outlook for profitability.
  • Recent analyst upgrades suggest positive sentiment, with several firms raising their price targets, reflecting confidence in the company's growth potential.
  • The current stock price is around $300, which is considered attractive given the company's solid fundamentals and growth prospects.
  • Laboratory Co. of America Holdings has a consistent dividend payout, with a recent quarterly dividend of $0.72, providing income to shareholders.
  • Institutional ownership is high, with nearly 96% of the stock held by institutional investors, indicating strong confidence from large investors in the company's future performance.

Labcorp
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Laboratory Co. of America Holdings for these reasons:

  • Despite recent earnings beats, the market reaction has been muted, suggesting that investors may have concerns about the company's future growth potential.
  • Guidance for the upcoming periods is only modestly above consensus estimates, which may limit upside potential for the stock.
  • Profit-taking after earnings reports can lead to short-term stock price declines, which may deter new investors.
  • Analysts have noted limited incremental upside in margin guidance, which could indicate challenges in maintaining profitability.
  • Market sentiment has shown some negativity, which could impact stock performance in the near term.

LH Forecast - Frequently Asked Questions

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Labcorp is $308.00, with a high forecast of $334.00 and a low forecast of $260.00.

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Labcorp in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" LH shares.

According to analysts, Labcorp's stock has a predicted upside of 23.05% based on their 12-month stock forecasts.

Labcorp has been rated by research analysts at Evercore, JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, Robert W. Baird, and Weiss Ratings in the past 90 days.

Analysts like Labcorp more than other "medical" companies. The consensus rating for Labcorp is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how LH compares to other companies.


This page (NYSE:LH) was last updated on 5/17/2026 by MarketBeat.com Staff.
From Our Partners